Case Studies
Accelerator™ Drug Development: Streamlining Preclinical Pathways for a Fast Transition to First-in-Human Trials
For emerging biotech companies, the path from preclinical development to first-in-human (FIH) trials can define the future of a therapy. Challenges such as regulatory hurdles, incomplete API characterization,and inefficient study design often lead to costly delays and lost momentum.
Packaging and labeling support for a global cell therapy program
As cell and gene therapies rapidly expand toward global patient populations, the need for highly reliable, multi-temperature packaging and labeling solutions has never been greater.
Help Reduce Risk. Respond Faster. Return to Operations Confidently.
Discover How Two Biopharma Facilities Transformed Their Bio-Decontamination Strategy Contamination events and annual shutdowns are high-risk moments that demand precision, speed, and validated outcomes.
